TABLE 1.
Demographic data and clinical measures (HbA1c, FBS) and concomitant disease of individuals enrolled in the study. N = 25. SD, standard deviation. HbA1c, glycated hemoglobin. FBS, fasting blood sugar.
| Variables | N = 25 |
|---|---|
| Age (years) | |
| Mean ± SD | 42.7 ± 10.7 |
| Variation | 25–65 |
| Gender | |
| Males | 52% |
| Females | 48% |
| HbA1c- before treatment (% mean ± SD) | 7.88% ± 0.82 |
| HbA1c- after treatment (% mean ± SD) | 7.54% ± 1.02 |
| FBS (mg/dl) (mean ± SD) | 184.6 ± 49.6 |
| FBS (mg/dl) (mean ± SD) | 192.2 ± 39.9 |
| Individuals with concomitant health problems (n, %) | |
| Hypertension | 11, 44% |
| Ischemic heart disease | 5, 20% |
| Heart failure | 2, 8% |
| History of myocardial infarction | 4, 16% |
| History of cerebrovascular accident | 1, 5% |
| Dyslipidemia | 12, 48% |
| Asthma | 2, 8% |
| Rheumatoid arthritis | 5, 2% |